Glickman Mark A
Insider CIK 1441461 · POZN Chief Commercial Officer · AUXL SVP - Sales · ESPR Chief Commercial Officer · NRBO Director · BSEM Director · ARLZ Chief Commercial officer · TXMD Co-Chief Executive Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BSEM BioStem Technologies, Inc. | M Exercise deriv | 2026-08-27 | 2026-08-28 | 7,671 | — | $0 | 0 | SEC↗ |
| BSEM BioStem Technologies, Inc. | M Exercise | 2026-08-27 | 2026-08-28 | 7,671 | — | $0 | 7,671 | SEC↗ |
| BSEM BioStem Technologies, Inc. | M Exercise deriv | 2026-08-27 | 2026-08-28 | 7,671 | — | $0 | 0 | SEC↗ |
| BSEM BioStem Technologies, Inc. | M Exercise | 2026-08-27 | 2026-08-28 | 7,671 | — | $0 | 7,671 | SEC↗ |
| MTVA MetaVia Inc. | A Award | 2026-06-08 | 2026-06-08 | 17,186 | — | $0 | 20,629 | SEC↗ |
| MTVA MetaVia Inc. | A Award | 2025-06-30 | 2025-07-01 | 28,147 | — | $0 | 37,887 | SEC↗ |
| NRBO NeuroBo Pharmaceuticals, I | A Award | 2024-06-07 | 2024-06-07 | 5,051 | — | $0 | 9,740 | SEC↗ |
| NRBO NeuroBo Pharmaceuticals, I | A Award | 2023-07-27 | 2023-07-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| NRBO NeuroBo Pharmaceuticals, I | A Award | 2023-07-27 | 2023-07-28 | 12,500 | — | $0 | 37,500 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise deriv | 2022-12-06 | 2022-12-09 | 1,734 | — | $0 | 3,466 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise | 2022-12-06 | 2022-12-09 | 1,734 | — | $0 | 1,734 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | S Sale | 2022-12-06 | 2022-12-09 | 440 | $4.92 | $2.2K | 1,294 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | A Award deriv | 2022-03-31 | 2022-03-31 | 260,000 | — | $0 | 260,000 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | A Award deriv | 2022-03-23 | 2022-03-28 | 260,000 | — | $0 | 260,000 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | A Award deriv | 2021-10-15 | 2021-10-15 | 260,000 | — | $0 | 260,000 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | A Award deriv | 2021-10-15 | 2021-10-15 | 260,000 | — | $0 | 260,000 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | A Award deriv | 2021-10-15 | 2021-10-15 | 400,000 | — | $0 | 400,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2020-01-02 | 2020-01-03 | 26,625 | — | $0 | 26,625 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award | 2020-01-02 | 2020-01-03 | 5,925 | — | $0 | 25,925 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | S Sale | 2018-03-19 | 2018-03-21 | 5,725 | $1.70 | $9.7K | 250,188 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | A Award deriv | 2017-05-11 | 2017-05-12 | 92,621 | — | $0 | 92,621 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | A Award | 2017-05-11 | 2017-05-12 | 80,163 | — | $0 | 255,913 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | F Tax w/h | 2016-06-22 | 2016-06-24 | 10,803 | $3.34 | $36.1K | 175,750 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | P Buy | 2016-05-16 | 2016-05-18 | 25,000 | $3.68 | $92.0K | 186,553 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | A Award deriv | 2016-03-17 | 2016-03-18 | 38,559 | — | $0 | 38,559 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | A Award | 2016-03-17 | 2016-03-18 | 45,553 | — | $0 | 161,553 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | A Award | 2016-02-12 | 2016-02-17 | 86,863 | — | $0 | 116,000 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | J Other | 2016-02-05 | 2016-02-09 | 29,137 | — | $0 | 29,137 | SEC↗ |
| POZN POZEN INC /NC | A Award | 2015-06-22 | 2015-06-24 | 29,137 | — | $0 | 29,137 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | J Other deriv | 2015-01-29 | 2015-01-30 | 27,500 | $36.53 | $1.00M | 0 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | J Other deriv | 2015-01-29 | 2015-01-30 | 24,750 | $36.53 | $904.1K | 0 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | J Other deriv | 2015-01-29 | 2015-01-30 | 31,200 | $36.53 | $1.14M | 0 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | J Other deriv | 2015-01-29 | 2015-01-30 | 5,000 | $36.53 | $182.7K | 0 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | J Other | 2015-01-29 | 2015-01-30 | 27,911 | $36.53 | $1.02M | 0 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | M Exercise deriv | 2014-11-20 | 2014-11-24 | 5,000 | — | $0 | 5,000 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | M Exercise deriv | 2014-11-20 | 2014-11-24 | 27,500 | — | $0 | 27,500 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | M Exercise deriv | 2014-11-20 | 2014-11-24 | 8,250 | — | $0 | 24,750 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | M Exercise | 2014-11-20 | 2014-11-24 | 5,000 | $26.87 | $134.3K | 67,613 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | M Exercise | 2014-11-20 | 2014-11-24 | 27,500 | $20.07 | $551.9K | 62,613 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | S Sale | 2014-11-20 | 2014-11-24 | 40,750 | $33.16 | $1.35M | 27,911 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | S Sale | 2014-11-20 | 2014-11-24 | 7,202 | $33.18 | $239.0K | 68,661 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | M Exercise | 2014-11-20 | 2014-11-24 | 8,250 | $18.30 | $151.0K | 75,863 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award deriv | 2014-02-18 | 2014-02-20 | 31,200 | — | $0 | 31,200 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award deriv | 2014-02-18 | 2014-02-20 | 24,000 | — | $0 | 24,000 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award | 2014-02-18 | 2014-02-20 | 12,500 | — | $0 | 35,113 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | F Tax w/h | 2014-02-18 | 2014-02-20 | 704 | $28.30 | $19.9K | 22,613 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award | 2014-02-18 | 2014-02-20 | 6,375 | — | $0 | 23,317 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award | 2014-02-18 | 2014-03-12 | 12,500 | — | $0 | 35,113 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | F Tax w/h | 2014-02-07 | 2014-02-11 | 1,986 | $23.68 | $47.0K | 16,942 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | F Tax w/h | 2014-02-03 | 2014-02-04 | 388 | $24.70 | $9.6K | 18,928 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award | 2013-02-07 | 2014-03-12 | 13,200 | — | $0 | 19,742 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award deriv | 2013-02-07 | 2013-02-11 | 33,000 | — | $0 | 33,000 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | F Tax w/h | 2013-02-07 | 2013-02-11 | 426 | $18.30 | $7.8K | 19,316 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award | 2013-02-07 | 2013-02-11 | 13,200 | — | $0 | 19,742 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award | 2013-02-07 | 2013-02-11 | 3,940 | — | $0 | 6,542 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | F Tax w/h | 2013-02-03 | 2013-02-05 | 398 | $18.85 | $7.5K | 2,602 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award deriv | 2012-07-19 | 2012-07-20 | 10,000 | — | $0 | 10,000 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award deriv | 2012-02-03 | 2012-02-07 | 55,000 | — | $0 | 55,000 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award | 2012-02-03 | 2012-02-07 | 3,000 | — | $0 | 3,000 | SEC↗ |